EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTED: Integrative network analysis and molecular dynamics simulations identify silibinin as a putative modulator of EMT–ferroptosis crosstalk in pancreatic ductal adenocarcinoma

Parthiban R, Bhavya Ekambaram, Ravichandran V, Mohan Raj V, Elumalai Perumal

Cell Death · 2026

DOI: 10.1016/j.celld.2026.100010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Death, 2026. Verfasst von Parthiban R und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) exhibits aggressive progression and therapeutic resistance driven by epithelial–mesenchymal transition (EMT) and dysregulated ferroptosis. Silibinin, a flavonolignan derived from Silybum marianum , has been reported to exert anti-metastatic and redox-modulating effects in pancreatic cancer models; however, its systems-level regulatory mechanisms linking EMT and ferroptosis remain poorly defined. In this study, an integrative in silico systems pharmacology framework was employed to explore the multitarget regulatory landscape of silibinin in PDAC. Predicted silibinin targets were intersected with PDAC-associated genes derived from TCGA and GEO datasets, followed by protein–protein interaction network construction, module detection, and pathway enrichment analyses. Key hub proteins involved in EMT and ferroptosis-associated signaling were further evaluated using molecular docking and 100-ns molecular dynamics simulations to assess binding stability and interaction dynamics. Network analysis identified central regulatory hubs, including SRC, AKT1, HIF1A, MMP9, KIT, KDR, MTOR, PIK3CA, and STAT1, enriched in PI3K–AKT signaling, proteoglycans in cancer, hypoxia response, and pathways linked to ferroptosis regulation. Docking and molecular dynamics simulations suggested stable and energetically favorable interactions between silibinin and selected EMT–ferroptosis-associated targets, particularly AKT1 and MET/KDR, supporting their potential relevance in PDAC signaling networks. Collectively, this study provides computational evidence supporting silibinin as a putative modulator of EMT–ferroptosis crosstalk in pancreatic cancer and establishes a mechanistic framework for future experimental validation. These findings may inform subsequent in vitro and in vivo investigations aimed at evaluating silibinin-based therapeutic strategies in PDAC

Zitieren

APA

R, P., Ekambaram, B., V, R., V, M. R., & Perumal, E. (2026). RETRACTED: Integrative network analysis and molecular dynamics simulations identify silibinin as a putative modulator of EMT–ferroptosis crosstalk in pancreatic ductal adenocarcinoma. Cell Death. https://doi.org/10.1016/j.celld.2026.100010

Vancouver

R P, Ekambaram B, V R, V MR, Perumal E. RETRACTED: Integrative network analysis and molecular dynamics simulations identify silibinin as a putative modulator of EMT–ferroptosis crosstalk in pancreatic ductal adenocarcinoma. Cell Death. 2026. doi:10.1016/j.celld.2026.100010

BibTeX
@article{R2026,
  author = {R, Parthiban and Ekambaram, Bhavya and V, Ravichandran and V, Mohan Raj and Perumal, Elumalai},
  title = {RETRACTED: Integrative network analysis and molecular dynamics simulations identify silibinin as a putative modulator of EMT–ferroptosis crosstalk in pancreatic ductal adenocarcinoma},
  journal = {Cell Death},
  year = {2026},
  doi = {10.1016/j.celld.2026.100010}
}
Kostenlos starten →